Functional characterization of human T cell hyporesponsiveness induced by CTLA4-Ig

PLoS ONE

Volumn 10, Issue 4, 2015, Pages

  Rochman, Yrina ^a,b   Yukawa, Masashi ^a   Kartashov, Andrey V ^a   Barski, Artem ^a  

^a UNIVERSITY OF CINCINNATI   (United States)

^b UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABATACEPT; CD45RA ANTIGEN; CD45RO ANTIGEN; CD69 ANTIGEN; CYCLIN DEPENDENT KINASE INHIBITOR 1B; GAMMA INTERFERON; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR ALPHA; INTERLEUKIN 7 RECEPTOR ALPHA; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE P38; PROTEIN KINASE ZAP 70; TRANSCRIPTION FACTOR AP 1; TRANSCRIPTION FACTOR NFAT; UBIQUITIN PROTEIN LIGASE E3; CYTOKINE; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; HYBRID PROTEIN; IMMUNOGLOBULIN; LYMPHOCYTE ANTIGEN RECEPTOR; MEMBRANE ANTIGEN; TRANSCRIPTOME; UBIQUITIN PROTEIN LIGASE;

ANTIGEN EXPRESSION; APOPTOSIS; ARTICLE; CD4+ T LYMPHOCYTE; CELL ENERGY; CELL SURVIVAL; CLONAL ANERGY; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DOWN REGULATION; DRUG MECHANISM; ENZYME PHOSPHORYLATION; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; IN VITRO STUDY; LYMPHOCYTE PROLIFERATION; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; REGULATORY T LYMPHOCYTE; SIGNAL TRANSDUCTION; T CELL DEPLETION; T LYMPHOCYTE ACTIVATION; UPREGULATION; BIOSYNTHESIS; DRUG EFFECTS; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENETICS; IMMUNOLOGICAL MEMORY; IMMUNOLOGY; IMMUNOPHENOTYPING; LYMPHOCYTE ACTIVATION; METABOLISM; PHENOTYPE; T LYMPHOCYTE; T LYMPHOCYTE SUBPOPULATION;

MURINAE;

ANTIGENS, SURFACE; CD4-POSITIVE T-LYMPHOCYTES; CLONAL ANERGY; CTLA-4 ANTIGEN; CYCLIN-DEPENDENT KINASE INHIBITOR P27; CYTOKINES; GENE EXPRESSION; GENE EXPRESSION PROFILING; HUMANS; IMMUNOGLOBULINS; IMMUNOLOGIC MEMORY; IMMUNOPHENOTYPING; LYMPHOCYTE ACTIVATION; PHENOTYPE; RECEPTORS, ANTIGEN, T-CELL; RECOMBINANT FUSION PROTEINS; SIGNAL TRANSDUCTION; T-LYMPHOCYTE SUBSETS; T-LYMPHOCYTES; T-LYMPHOCYTES, REGULATORY; TRANSCRIPTOME; UBIQUITIN-PROTEIN LIGASES;

EID: 84928781522     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0122198     Document Type: Article

References (46)

1. Choi S, Schwartz RH (2007) Molecular mechanisms for adaptive tolerance and other T cell anergy models. Semin Immunol 19: 140-152. PMID: 17400472
2. Chen L, Flies DB (2013) Molecular mechanisms of T cell co-stimulation and co-inhibition. Nat Rev Immunol 13: 227-242. doi: 10.1038/nri3405 PMID: 23470321
3. Wekerle T, Kurtz J, Bigenzahn S, Takeuchi Y, Sykes M (2002) Mechanisms of transplant tolerance induction using costimulatory blockade. Curr Opin Immunol 14: 592-600. PMID: 12183158
4. Wekerle T, Grinyó JM (2012) Belatacept: from rational design to clinical application. Transpl Int 25: 139-150. doi: 10.1111/j.1432-2277.2011.01386.x PMID: 22151353
5. Wells AD, Walsh MC, Bluestone JA, Turka LA (2001) Signaling through CD28 and CTLA-4 controls two distinct forms of T cell anergy. J Clin Invest 108: 895-903. PMID: 11560959
6. Webb LM, Walmsley MJ, Feldmann M (1996) Prevention and amelioration of collagen-induced arthritis by blockade of the CD28 co-stimulatory pathway: requirement for both B7-1 and B7-2. Eur J Immunol 26: 2320-2328. PMID: 8898940
7. Lenschow DJ, Ho SC, Sattar H, Rhee L, Gray G, et al. (1995) Differential effects of anti-B7-1 and anti-B7-2 monoclonal antibody treatment on the development of diabetes in the nonobese diabetic mouse. J Exp Med 181: 1145-1155. PMID: 7532678
8. Linsley PS, Nadler SG (2009) The clinical utility of inhibiting CD28-mediated costimulation. Immunol Rev 229: 307-321. doi: 10.1111/j.1600-065X.2009.00780.x PMID: 19426230
9. Silva M V, Machado JR, Rocha LP, Castellano LR, Reis MA, et al. (2012) CD28 Family and Chronic Rejection: "To Belatacept...and Beyond!." J Transplant 2012: 1-14.
10. Keane-Myers A, Gause WC, Linsley PS, Chen SJ, Wills-Karp M (1997) B7-CD28/CTLA-4 costimulatory pathways are required for the development of T helper cell 2-mediated allergic airway responses to inhaled antigens. J Immunol 158: 2042-2049. PMID: 9036947
11. Padrid P, Mathur M, Li X, Herrmann K, Qin Y, et al. (1998) CTLA4Ig inhibits airway eosinophilia and hyperresponsiveness by regulating the development of Th1/Th2 subsets in a murine model of asthma. Am J Respir Cell Mol Biol 18: 453-462. PMID: 9533932
12. Van Oosterhout AJM, Hofstra CL, Shields R, Chan B, Van Ark I, et al. (1997) Murine CTLA4-IgG Treatment Inhibits Airway Eosinophilia and Hyperresponsiveness and Attenuates IgE Upregulation in a Murine Model of Allergic Asthma. Am J Respir Cell Mol Biol 17: 386-392. PMID: 9308926
13. Caporali R, Bugatti S, Cavagna L, Antivalle M, Sarzi-Puttini P (2014) Modulating the co-stimulatory signal for T cell activation in rheumatoid arthritis: could it be the first step of the treatment? Autoimmun Rev 13: 49-53. doi: 10.1016/j.autrev.2013.06.008 PMID: 23777823
14. Merrill JT, Burgos-Vargas R, Westhovens R, Chalmers A, D'Cruz D, et al. (2010) The efficacy and safety of abatacept in patients with non-life-threatening manifestations of systemic lupus erythematosus: Results of a twelve-month, multicenter, exploratory, phase IIb, randomized, double-blind, placebo-controlled trial. Arthritis Rheum 62: 3077-3087. doi: 10.1002/art.27601 PMID: 20533545
15. Orban T, Bundy B, Becker DJ, DiMeglio L, Gitelman SE, et al. (2011) Co-stimulation modulation with abatacept in patients with recent-onset type 1 diabetes: a randomised, double-blind, placebo-controlled trial. Lancet 378: 412-419. doi: 10.1016/S0140-6736(11)60886-6 PMID: 21719096
16. Mayer L, Kaser A, Blumberg RS (2012) Dead on arrival: understanding the failure of CTLA4-immunoglobulin therapy in inflammatory bowel disease. Gastroenterology 143: 13-17. doi: 10.1053/j.gastro.2012.05.015 PMID: 22626501
17. Sandborn WJ, Colombel J-F, Sands BE, Rutgeerts P, Targan SR, et al. (2012) Abatacept for Crohn's disease and ulcerative colitis. Gastroenterology 143: 62-69.e4. doi: 10.1053/j.gastro.2012.04.010 PMID: 22504093
18. Parulekar AD, Boomer JS, Patterson BM, Yin-Declue H, Deppong CM, et al. (2013) A randomized controlled trial to evaluate inhibition of T-cell costimulation in allergen-induced airway inflammation. Am J Respir Crit Care Med 187: 494-501. doi: 10.1164/rccm.201207-1205OC PMID: 23292882
19. Keane-Myers A, Gause WC, Linsley PS, Chen SJ, Wills-Karp M (1997) B7-CD28/CTLA-4 costimulatory pathways are required for the development of T helper cell 2-mediated allergic airway responses to inhaled antigens. J Immunol 158: 2042-2049. PMID: 9036947
20. Tan P, Anasetti C, Hansen JA, Melrose J, Brunvand M, et al. (1993) Induction of alloantigen-specific hyporesponsiveness in human T lymphocytes by blocking interaction of CD28 with its natural ligand B7/BB1. J Exp Med 177: 165-173. PMID: 7678111
21. Thomas RM, Chunder N, Chen C, Umetsu SE, Winandy S, et al. (2007) Ikaros enforces the costimulatory requirement for IL2 gene expression and is required for anergy induction in CD4+ T lymphocytes. J Immunol 179: 7305-7315. PMID: 18025173
22. Rowell EA, Wang L, Hancock WW, Wells AD (2006) The cyclin-dependent kinase inhibitor p27kip1 is required for transplantation tolerance induced by costimulatory blockade. J Immunol 177: 5169-5176. PMID: 17015702
23. Rowell EA, Walsh MC, Wells AD (2005) Opposing roles for the cyclin-dependent kinase inhibitor p27kip1 in the control of CD4+ T cell proliferation and effector function. J Immunol 174: 3359-3368. PMID: 15749868
24. Boussiotis VA, Freeman GJ, Taylor PA, Berezovskaya A, Grass I, et al. (2000) p27kip1 functions as an anergy factor inhibiting interleukin 2 transcription and clonal expansion of alloreactive human and mouse helper T lymphocytes. Nat Med 6: 290-297. PMID: 10700231
25. Levin JZ, Yassour M, Adiconis X, Nusbaum C, Thompson DA, et al. (2010) Comprehensive comparative analysis of strand-specific RNA sequencing methods. Nat Methods 7: 709-715. doi: 10.1038/nmeth.1491 PMID: 20711195
26. Kartashov AV, Barski A (2014) Wardrobe - an integrated system for analysis of epigenomics and transcriptomics data. bioRxiv: 012799. Available: http://biorxiv.org/content/early/2014/12/22/012799.abstract.
27. Dobin A, Davis CA, Schlesinger F, Drenkow J, Zaleski C, et al. (2013) STAR: Ultrafast universal RNA-seq aligner. Bioinformatics 29: 15-21. doi: 10.1093/bioinformatics/bts635 PMID: 23104886
28. Anders S, Huber W (2010) Differential expression analysis for sequence count data. Genome Biol 11: R106. doi: 10.1186/gb-2010-11-10-r106 PMID: 20979621
29. Chen J, Bardes EE, Aronow BJ, Jegga AG (2009) ToppGene Suite for gene list enrichment analysis and candidate gene prioritization. Nucleic Acids Res 37: W305-W311. doi: 10.1093/nar/gkp427 PMID: 19465376
30. Brownlie RJ, Zamoyska R (2013) T cell receptor signalling networks: branched, diversified and bounded. Nat Rev Immunol 13: 257-269. doi: 10.1038/nri3403 PMID: 23524462
31. Rengarajan J, Mittelstadt PR, Mages HW, Gerth AJ, Kroczek RA, et al. (2000) Sequential involvement of NFAT and Egr transcription factors in FasL regulation. Immunity 12: 293-300. PMID: 10755616
32. Schwartz RH (2003) T cell anergy. Annu Rev Immunol 21: 305-334. PMID: 12471050
33. Heissmeyer V, Macián F, Im S- H, Varma R, Feske S, et al. (2004) Calcineurin imposes T cell unresponsiveness through targeted proteolysis of signaling proteins. Nat Immunol 5: 255-265. PMID: 14973438
34. Pagano M, Tam SW, Theodoras AM, Beer-Romero P, Del Sal G, et al. (1995) Role of the ubiquitin-proteasome pathway in regulating abundance of the cyclin-dependent kinase inhibitor p27. Science 269: 682-685. PMID: 7624798
35. Li L, Iwamoto Y, Berezovskaya A, Boussiotis VA (2006) A pathway regulated by cell cycle inhibitor p27Kip1 and checkpoint inhibitor Smad3 is involved in the induction of T cell tolerance. Nat Immunol 7: 1157-1165. PMID: 17013388
36. Zheng Y, Zha Y, Driessens G, Locke F, Gajewski TF (2012) Transcriptional regulator early growth response gene 2 (Egr2) is required for T cell anergy in vitro and in vivo. J Exp Med 209: 2157-2163. doi: 10.1084/jem.20120342 PMID: 23129747
37. Zha Y, Marks R, Ho AW, Peterson AC, Janardhan S, et al. (2006) T cell anergy is reversed by active Ras and is regulated by diacylglycerol kinase-alpha. Nat Immunol 7: 1166-1173. PMID: 17028589
38. Safford M, Collins S, Lutz M, Allen A, Huang C- T, et al. (2005) Egr-2 and Egr-3 are negative regulators of T cell activation. Nat Immunol 6: 472-480. PMID: 15834410
39. Zheng Y, Zha Y, Gajewski TF (2008) Molecular regulation of T-cell anergy. EMBO Rep 9: 50-55. doi: 10.1038/sj.embor.7401138 PMID: 18174897
40. Collins S, Lutz M, Zarek PE, Anders R, Kersh GJ, et al. (2008) Opposing regulation of T cell function by Egr-1/NAB2 and Egr-2/Egr-3. Eur J Immunol 38: 528-536. doi: 10.1002/eji.200737157 PMID: 18203138
41. Polyak K, Lee MH, Erdjument-Bromage H, Koff A, Roberts JM, et al. (1994) Cloning of p27Kip1, a cyclin-dependent kinase inhibitor and a potential mediator of extracellular antimitogenic signals. Cell 78: 59-66. PMID: 8033212
42. Powell JD, Bruniquel D, Schwartz RH (2001) TCR engagement in the absence of cell cycle progression leads to T cell anergy independent of p27Kip1. Eur J Immunol 31: 3737-3746. PMID: 11745394
43. Riella LV, Liu T, Yang J, Chock S, Shimizu T, et al. (2012) Deleterious effect of CTLA4-Ig on a Tregdependent transplant model. Am J Transplant 12: 846-855. doi: 10.1111/j.1600-6143.2011.03929.x PMID: 22300534
44. Xue H- H, Kovanen PE, Pise-Masison C, Berg M, Radovich MF, et al. (2002) IL-2 negatively regulates IL-7 receptor alpha chain expression in activated T lymphocytes. Proc Natl Acad Sci U S A 99: 13759-13764. PMID: 12354940
45. Mazzucchelli R, Durum SK (2007) Interleukin-7 receptor expression: intelligent design. Nat Rev Immunol 7: 144-154. PMID: 17259970
46. Liao W, Lin J-X, Leonard WJ (2013) Interleukin-2 at the crossroads of effector responses, tolerance, and immunotherapy. Immunity 38: 13-25. doi: 10.1016/j.immuni.2013.01.004 PMID: 23352221